Following the success of previous biennials, the CMC 2026 Distilled is scheduled for Wednesday, April 15, 2026. This one-day virtual summit serves as a high-density clinical update on the management of breast, ovarian, cervical, and endometrial cancers. Broadcast live from a professional TV studio in Berlin, the conference utilizes a “distilled” format to translate complex scientific data into actionable clinical practice.
The 2026 program is built around four primary medical blocks, featuring Presidential Lectures, State-of-the-Art sessions, and interdisciplinary panel discussions led by the Charité–Mayo faculty. Key topics for 2026 include the evolving role of surgery in the era of targeted therapies, the strategic use of Antibody-Drug Conjugates (ADCs), and molecular classification in endometrial cancer. The event remains committed to its mission of global knowledge-sharing by offering free registration to all international healthcare professionals and awarding 10 CME points (State Chamber Berlin).
The event is organized by Charité – Universitätsmedizin Berlin in partnership with the Mayo Clinic, under the leadership of Conference Chairs Prof. Dr. Jalid Sehouli and Prof. Dr. Jens-Uwe Blohmer (Charité, Berlin), alongside Scientific Board members Prof. Dr. Sean C. Dowdy and Prof. Dr. Carrie L. Langstraat (Mayo Clinic, USA).